Research Project: Nsclc Tedavisinde Hedefe Yönelik Egfr İnhibitörlerinin Sentezlenmesi, Antikanser Etki Mekanizmalarının Araştırılması ve Yapısal Dinamik Çalışmaları
| dc.contributor.department | Department of Molecular Biology and Genetics | |
| dc.contributor.department | Department of Molecular Biology and Genetics | |
| dc.contributor.schoolcollegeinstitute | College of Sciences | |
| dc.contributor.schoolcollegeinstitute | College of Sciences | |
| dc.date.accessioned | 2024-12-29T10:39:46Z | |
| dc.date.available | 2024-12-29 | |
| dc.description.publisherscope | National | |
| dc.identifier | TB.00703 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14288/24947 | |
| dc.relation.affiliation | Koç University | |
| dc.relation.collection | Koç University Projects Collection | |
| dc.title | Nsclc Tedavisinde Hedefe Yönelik Egfr İnhibitörlerinin Sentezlenmesi, Antikanser Etki Mekanizmalarının Araştırılması ve Yapısal Dinamik Çalışmaları | |
| dc.title.alternative | Nsclc Tedavisinde Hedefe Yönelik Egfr İn | |
| dspace.entity.type | Project | |
| local.contributor.kuauthor | Çiftçi, Halilibrahim | |
| local.project.contractnumber | 122Z775 | |
| local.project.endDate | 2025-10-31 | |
| local.project.startDate | 2022-10-31 | |
| local.project.template | TB.ARDEB.1001 | |
| project.funder.identifier | TÜBİTAK | |
| project.funder.name | TÜBİTAK | |
| project.investigator | Çiftçi, Halil İbrahim | |
| relation.isOrgUnitOfProject | aee2d329-aabe-4b58-ba67-09dbf8575547 | |
| relation.isOrgUnitOfProject.latestForDiscovery | aee2d329-aabe-4b58-ba67-09dbf8575547 | |
| relation.isParentOrgUnitOfProject | af0395b0-7219-4165-a909-7016fa30932d | |
| relation.isParentOrgUnitOfProject.latestForDiscovery | af0395b0-7219-4165-a909-7016fa30932d | |
| relation.isPersonOfProject | b18bed7d-bf94-41e2-b379-b7ee0d5dee24 | |
| relation.isPersonOfProject.latestForDiscovery | b18bed7d-bf94-41e2-b379-b7ee0d5dee24 |
